Industry
Medical - Devices
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Loading...
Open
7.56
Mkt cap
88M
Volume
26K
High
7.78
P/E Ratio
-5.17
52-wk high
8.17
Low
7.45
Div yield
N/A
52-wk low
2.25
Portfolio Pulse from
November 07, 2024 | 12:15 pm
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 11:30 am
Portfolio Pulse from Benzinga Newsdesk
August 07, 2024 | 11:25 am
Portfolio Pulse from Benzinga Newsdesk
May 09, 2024 | 11:13 am
Portfolio Pulse from Benzinga Newsdesk
March 19, 2024 | 5:40 pm
Portfolio Pulse from Benzinga Newsdesk
March 04, 2024 | 12:02 pm
Portfolio Pulse from Benzinga Insights
March 04, 2024 | 9:53 am
Portfolio Pulse from Benzinga Insights
March 01, 2024 | 3:02 pm
Portfolio Pulse from totan@benzinga.com
November 09, 2023 | 12:08 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.